NCT03238222

Brief Summary

Peripheral arterial disease can cause leg pain or discomfort (called intermittent claudication (IC)), which limits the ability to walk and carry out everyday activities. Lifestyle changes, like increasing walking, can lead to improvements, but can be a challenge to begin and then continue. The aim of this study is to investigate if a physiotherapist-led, behaviour change treatment effects walking in people with IC. The treatment is designed to build an understanding of IC and walking exercise and help individuals develop strategies to increase regular walking. The trial will recruit 192 adults (aged 50 years and over) with IC. All participants will visit King's College London or their local hospital to complete two short walking tests and answer questionnaires about their daily activities, beliefs about their symptoms and treatment, quality of life and the costs of having IC. Participants will then be randomly assigned to receive either the new treatment or continue with their usual NHS care. The new treatment involves two 60-minute face-to-face sessions (at the participant's home or local hospital) and two 20-minute telephone calls with a physiotherapist who will discuss participants' understanding and beliefs about IC, walking and help participants to set goals and plans to increase walking over 12 weeks. Participants will be provided with a step counter (pedometer) and walking record. After 12 weeks, all participants will attend a second appointment where they will repeat the walking tests and fill out another set of questionnaires. A final set of questionnaires will be completed by all participants after 6 months (by post or electronically). Some participants will be invited to provide feedback on their experience of the treatment and trial by telephone or a face-to-face interview with a researcher.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
192

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable

Geographic Reach
1 country

9 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 3, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

November 10, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 9, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 9, 2021

Completed
Last Updated

December 11, 2019

Status Verified

December 1, 2019

Enrollment Period

3 years

First QC Date

August 1, 2017

Last Update Submit

December 10, 2019

Conditions

Keywords

WalkingSix-Minute Walk DistanceIllness PerceptionsTheory of Planned Behaviour

Outcome Measures

Primary Outcomes (1)

  • 6 Minute Walk Distance

    6 Minute Walking Distance (in metres) measured during a self-paced, standardised 6 Minute Walk Test conducted around a level, 100-foot circuit.

    3 months

Secondary Outcomes (5)

  • 6 Minute Walk Distance (6MWD)

    Baseline and 3 months

  • Self-reported Maximum Walking Distance

    Baseline, 3 and 6 months

  • Self-Reported Walking Ability

    Baseline, 3 and 6 months

  • Activities of Daily Living

    Baseline, 3 and 6 months

  • Health-Related Quality of Life

    Baseline, 3 and 6 months

Other Outcomes (7)

  • Treatment Cognitions

    Baseline, 3 and 6 months

  • Illness Cognitions

    Baseline, 3 and 6 months

  • Walking Adherence

    Baseline, 3 and 6 months

  • +4 more other outcomes

Study Arms (2)

MOSAIC Treatment

EXPERIMENTAL

MOSAIC treatment plus Usual NHS Care. MOSAIC treatment comprises 2 x 60-minute individual face-to-face consultations (weeks 1 \& 2) and 2 x 20-minute follow-up telephone calls (weeks 6 \& 12) with a trained physiotherapist.

Behavioral: MOSAIC

Usual Care Comparison

NO INTERVENTION

Usual NHS care for people with intermittent claudication typically consists of an initial assessment, drug therapy and simple advice to walk provided by a vascular specialist and delivered in the vascular outpatient clinic.

Interventions

MOSAICBEHAVIORAL

MOSAIC comprises 2 x 60-minute individual face-to-face consultations (weeks 1 \& 2) and 2 x 20-minute follow-up telephone calls (weeks 6 \& 12) delivered at a convenient time and location of participant's choice (local NHS Trust or participant's home). All sessions are delivered by a trained Band 6/7 physiotherapist. All participants randomized to receive MOSAIC will be provided with a pedometer and a patient manual which will include information on intermittent claudication, risk factors, walking guidelines, goal setting, problem solving and action planning worksheets and a walking diary.

Also known as: Motivating Structured walking Activity in IC
MOSAIC Treatment

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥50 years of age;
  • established PAD (Ankle Brachial Pressure Index ≤0.90 and/or radiographic evidence or clinician reported diagnosis) and IC (presence of symptoms reported on the San Diego Claudication Questionnaire)
  • able to participate in MOSAIC
  • able and willing to provide informed consent

You may not qualify if:

  • Unstable IC (self-reported change in symptoms during previous 3 months)
  • walking \>90 minutes/week (reported on Brief International Physical Activity Questionnaire
  • contraindications to walking exercise (e.g., unstable angina) confirmed by their vascular specialist
  • have completed any prescribed supervised exercise sessions in the previous 6 months or been offered prescribed exercise sessions in the next 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Dartford and Gravesham NHS Trust (GSTT PIC site)

Dartford, Kent, United Kingdom

RECRUITING

Maidstone and Tunbridge Wells NHS Trust (GSTT PIC site)

Maidstone, Kent, United Kingdom

RECRUITING

Ashford & St Peter's NHS Foundation Trust

Ashford, Surrey, United Kingdom

RECRUITING

Guy's & St Thomas NHS Foundation Trust

London, United Kingdom

RECRUITING

King's College Hospital NHS Foundation Trust

London, United Kingdom

RECRUITING

Lewisham and Greenwich NHS Trust (GSTT PIC site)

London, United Kingdom

RECRUITING

Royal Free London NHS Foundation Trust

London, United Kingdom

RECRUITING

St George's University Hospital NHS Foundation Trust

London, United Kingdom

RECRUITING

The Royal London Hospital, Barts Heatth NHS Trust

London, United Kingdom

RECRUITING

Related Publications (1)

  • Bearne LM, Volkmer B, Peacock J, Sekhon M, Fisher G, Galea Holmes MN, Douiri A, Amirova A, Farran D, Quirke-McFarlane S, Modarai B, Sackley C, Weinman J, Bieles J; MOSAIC Trial Collaboration. Effect of a Home-Based, Walking Exercise Behavior Change Intervention vs Usual Care on Walking in Adults With Peripheral Artery Disease: The MOSAIC Randomized Clinical Trial. JAMA. 2022 Apr 12;327(14):1344-1355. doi: 10.1001/jama.2022.3391.

MeSH Terms

Conditions

Peripheral Arterial DiseaseIntermittent ClaudicationPeripheral Vascular Diseases

Interventions

Mosaicism

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Chromosome AberrationsMutationGenetic VariationGenetic Phenomena

Study Officials

  • Sanjay Patel

    Guy's and St Thomas' NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Julie S Bieles, PhD

CONTACT

Lindsay Bearne, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2017

First Posted

August 3, 2017

Study Start

November 10, 2017

Primary Completion

November 9, 2020

Study Completion

January 9, 2021

Last Updated

December 11, 2019

Record last verified: 2019-12

Locations